EUVIMEDEUVIMED entdecken
Crossref

Histological assessment of treatment effect in lymph node‐positive breast cancer after neoadjuvant chemotherapy

Yihong Wang iD, Jess Hart, Mariana Canepa iD, Diana O Treaba, Liang Cheng iD

Histopathology · 2026-12 · 89 (6) · 1020-1030

DOI: 10.1111/his.70256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 04.08.2026. Verfasst von Yihong Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Brown University Health, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymph Nodes. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Neoadjuvant chemotherapy (NACT) is becoming the standard of care for lymph node (LN)‐positive breast cancers. Residual disease in the breast and LN serves as a critical prognostic indicator and guides adjuvant therapy. The histological patterns of LN treatment response (TE) vary significantly, and criteria for evaluating TE remain underdeveloped. Methods and Results We analysed 114 clinical node‐positive cases that underwent NACT, reviewed post‐NACT LN TE, and correlated them with clinicopathological characteristics. TE was identifiable in 77% of all cases and 92% of post‐NACT nodal conversion cases. The histological patterns of TE include a special “rounded” pattern of fibrosis (86%), LN architectural irregularity with aggregates of histocytes, foamy macrophages, and haemosiderin deposition (54%), and fine‐needle aspirated site changes (34%). Microscopically identifiable TE, except fibrosis, diminishes as the interval between LN sampling and surgery increases. Specifically, among the four cases that failed to identify TE in the nodal conversion group, 3 (75%) surgeries were performed >6 months after initial LN sampling. In cases with multiple clinically suspicious LNs, only one of which was sampled pre‐NACT, recognition of a specific fibrosis pattern allowed identification of TE in unsampled LNs (9 cases, 18%) post‐NACT, contributing to an accurate post‐NACT assessment. Post‐NACT nodal‐positive cases correlated with poor outcomes.

Conclusions

Given the paradigm shift of increased NACT, evaluation of TE in LN is critically important. Awareness of the histological features of TE is crucial for LN assessment to ensure accurate nodal removal and guide post‐NACT clinical management for best patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLymph NodesHumansFemaleNeoadjuvant TherapyLymphatic MetastasisChemotherapy, AdjuvantMiddle AgedAdultAgedTreatment OutcomeNeoplasm, Residual

Stichwörter der Autor:innen

breast cancerlymph nodeneoadjuvant chemotherapynode‐positiveresidual disease

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Brown University Health, Providence, Rhode Island, USA.

ORCID-Profile: Yihong Wang, Mariana Canepa, Liang Cheng

Zitieren

APA

Wang, Y., Hart, J., Canepa, M., Treaba, D. O., & Cheng, L. (2026). Histological assessment of treatment effect in lymph node‐positive breast cancer after neoadjuvant chemotherapy. Histopathology, 89(6), 1020-1030. https://doi.org/10.1111/his.70256

Vancouver

Wang Y, Hart J, Canepa M, Treaba DO, Cheng L. Histological assessment of treatment effect in lymph node‐positive breast cancer after neoadjuvant chemotherapy. Histopathology. 2026;89(6):1020-1030. doi:10.1111/his.70256

BibTeX
@article{Wang2026,
  author = {Wang, Yihong and Hart, Jess and Canepa, Mariana and Treaba, Diana O and Cheng, Liang},
  title = {Histological assessment of treatment effect in lymph node‐positive breast cancer after neoadjuvant chemotherapy},
  journal = {Histopathology},
  year = {2026},
  volume = {89},
  number = {6},
  pages = {1020--1030},
  doi = {10.1111/his.70256}
}
Kostenlos starten →